CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Gilead Sciences Inc  (GILD)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

Gilead Sciences Inc

GILD's Fundamental analysis






Gilead Sciences Inc's sales fell by -14.07 % in III. Quarter 2018 from the same quarter a year ago. Ranking at No. 2433

Biotechnology & Drugs industry recorded growth of revenues by 3.51 %

Gilead Sciences Inc's net profit deacreased by -22.6 % in III. Quarter 2018 year on year, to $2,099 millions.

More on GILD's Growth




Gilead Sciences Inc
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Company is currently trading with Price to Cash flow multiple of 29.55 in trailing twelve-month period.
Company
56.17
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 4.06.
Biotechnology & Drugs industry's Price to Sales ratio is at 5.12.
With annual estimated revenue growth of 13 % for 2015, Company's P/S ratio deteriorated to 3.07.

More on GILD's Valuation

 Market Capitalization (Millions $) 90,444
 Shares Outstanding (Millions) 1,307
 Employees 7,000
 Revenues (TTM) (Millions $) 22,281
 Net Income (TTM) (Millions $) 1,621
 Cash Flow (TTM) (Millions $) 3,061
 Capital Exp. (TTM) (Millions $) -896
 Total Debt (Millions $) 27,317
 Dividend TTM ($) 2.23 $
 Dividend Yield TTM (%) 3.29 %
 Revenue/Employee (TTM) $ 3,183,000
 Net Income/Employee (TTM) $ 231,571
 Receivable Turnover Ratio (TTM) 6.09
 Tangible Book Value (Per Share $) 1.97

 Market Capitalization (Millions $) 90,444
 Shares Outstanding (Millions) 1,307
 Employees 7,000
 Revenues (TTM) (Millions $) 22,281
 Net Income (TTM) (Millions $) 1,621
 Cash Flow (TTM) (Millions $) 3,061
 Capital Exp. (TTM) (Millions $) -896
 Total Debt (Millions $) 27,317
 Dividend TTM ($) 2.23 $
 Dividend Yield TTM (%) 3.29 %
 Revenue/Employee (TTM) $ 3,183,000
 Net Income/Employee (TTM) $ 231,571
 Receivable Turnover (TTM) 6.09
 Tangible Book Value (Per Share $) 1.97

Profitability
Profitability by Segment

Gilead Sciences Inc achieved increase in profitability, due to cost control. Operating Margin grew in III. Quarter 2018 to 46.87 % from 40.37 % in II. Quarter.

Gilead Sciences Inc net profit margin of 37.51 % is currently ranking no. 10 in Biotechnology & Drugs industry, ranking no. 24 in Healthcare sector and number 254 in S&P 500.

More on GILD's Key Ratios
You need to upgrade your Flash Player

You need to upgrade your Flash Player
  Ratio
   Capital Ratio (MRQ) 6.17
  Total Debt to Equity (MRQ) 1.19
  Tangible Leverage Ratio (MRQ) 14.36
  Asset Turnover Ratio (TTM) 0.34
  Inventory Turnover Ratio (TTM) 5.4



Gilead Sciences Inc achieved increase in profitability, due to cost control. Operating Margin grew in III. Quarter 2018 to 46.87 % from 40.37 % in II. Quarter.

Gilead Sciences Inc net profit margin of 37.51 % is currently ranking no. 10 in Biotechnology & Drugs industry, ranking no. 24 in Healthcare sector and number 254 in S&P 500.

More on GILD's Key Ratios


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BTHE's Profile

Stock Price

BTHE's Financials

Business Description

Fundamentals

Charts & Quotes

BTHE's News

Suppliers

BTHE's Competitors

Customers & Markets

Economic Indicators

BTHE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071